Jeffrey Cohen, MD

• Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
• Director, Mellen Center Experimental Therapeutics Program
• Director, Mellen Center Neuroimmunology Fellowship
• Former Director, Mellen Center
• Former Chair, International Advisory Committee on Clinical Trials, sponsored by National MS Society and ECTRIMS
• Former President, ACTRIMS 

• Freshman Chemistry Award, Connecticut College, 1973
• Sophomore Zoology Award, Connecticut College, 1974
• Junior Zoology Award, Connecticut College, 1975
• Winthrop Scholarship Award, Connecticut College, 1975
• Phi Beta Kappa, Connecticut College, 1976
• Alpha Omega Alpha, University of Chicago, 1980
• Clinician-Investigator Development Award, National Institute of Neurological Disorders and Stroke, 1988
• Distinguished Alumnus, Connecticut College, 1994
• American Neurological Association, 1998
• Health Professional of the Year, Ohio Buckeye Chapter, National Multiple Sclerosis Society, 2001
• Volunteer Hall of Fame, Health Professionals/Researchers, National Multiple Sclerosis Society, 2007
• Best Doctors in America
• Top Doctors, Cleveland Magazine
• America’s Top Doctors, Castle Connolly
• Maria and Sam Miller Professional Excellence Award in Clinical Research, Cleveland Clinic
• Giants of MS - Neurology, Consortium of MS Center

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-01-07, Dr. Cohen has reported the financial relationships with the companies listed below.

Consulting and/or Speaking. Dr. Cohen receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Kite Pharma, Inc.
• Convelo Therapeutics, Inc.
• Bristol-Myers Squibb

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.